Jason Scott Goldstein

Jason S. Goldstein is a nationally recognized mass tort attorney and Senior Litigation Counsel at Parker Waichman LLP. He focuses his practice on representing plaintiffs in complex pharmaceutical, medical device, and product liability litigations across the United States. Widely regarded as a leader in federal multidistrict litigation (MDL), Jason is frequently appointed to leadership positions in some of the most significant mass tort actions in the country. MDL Leadership & AppointmentsMr. Goldstein is known for his strategic oversight and trial-ready case development in scientifically complex claims. His leadership roles within Plaintiffs’ Steering Committees (PSC) include:In re: GLP-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation: Member of the Plaintiffs’ Steering re: Exactech Polyethylene Orthopedic Products Liability Litigation(MDL No. 3044): Member of the Plaintiffs’ Steering re: Elmiron (Pentosan Polysulfate Sodium) Products LiabilityLitigation (MDL No. 2973):* Committee Trial ExperienceJason has been a key member of trial teams that have secured some of the largest verdicts in the history of product liability litigation:Johnson & Johnson Talcum Powder Litigation: Served on the trial team that secured a $4.69 billion verdict for women diagnosed with ovarian Pinnacle Hip Implant Litigation: Contributed to multiple landmark trial victories, with verdicts ranging from $247 million to over $1 Recognition & Speaking Engagements A sought-after voice in the legal community, Jason regularly presents on emerging pharmaceutical litigation, MDL leadership strategy, and best practices in case development. He is a frequent speaker at premier industry conferences, including:Mass Torts Made Perfect (MTMP)Harris Martin ProgramsHonors & Awards:The National Trial Lawyers: “Top 40 Under 40”Jason’s practice is defined by his ability to navigate high-stakes litigation involving defective drugs, orthopedic implants, and consumer products. His deep experience in handling complex scientific evidence and his commitment to plaintiff advocacy have made him a leading figure in the national mass tort bar.